Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

REPLIGEN CORPORATION

(RGEN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies
CommuniquÚs de presse de la sociÚtÚ REPLIGEN CORPORATION
01/04REPLIGEN CORP : Change in Directors or Principal Officers, Financial Statements and Exhibi..
AQ
2021Repligen Corporation to Present at 40th Annual J.P. Morgan Healthcare Conference
AQ
2021REPLIGEN CORP : Regulation FD Disclosure, Other Events, Financial Statements and Exhibits ..
AQ
2021Repligen Corporation to Present at Upcoming Investor Conferences
GL
2021Repligen Releases Inaugural Sustainability Report
AQ
2021Repligen Releases Inaugural Sustainability Report
AQ
2021REPLIGEN CORP MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS ..
AQ
2021Repligen Reports Third Quarter 2021 Financial Results and Updates Full Year 2021 Financ..
PU
2021REPLIGEN : Q3 Earnings Snapshot
AQ
2021Repligen Reports Third Quarter 2021 Financial Results and Updates Full Year 2021 Financ..
AQ
2021REPLIGEN : to Report Third Quarter 2021 Financial Results
GL
2021REPLIGEN : Announces Agreement to Acquire Avitide Inc (Form 8-K)
PU
2021REPLIGEN CORP : Regulation FD Disclosure, Other Events, Financial Statements and Exhibits ..
AQ
2021Repligen Announces Agreement to Acquire Avitide Inc.
GL
2021REPLIGEN : and Navigo GmbH Announce Launch of Industry-First Protein A Ligand for Purifica..
AQ
2021REPLIGEN : and Navigo GmbH Announce Launch of Industry-FirstáProtein A Ligand for Purifica..
AQ
2021REPLIGEN : Extends Long Term Supply Agreement with Cytiva for Affinity Ligands
AQ
2021REPLIGEN CORP : Other Events (form 8-K)
AQ
2021REPLIGEN : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPER..
AQ
2021REPLIGEN : Reports Second Quarter 2021 Financial Results and Updates Full Year 2021 Financ..
PU
2021REPLIGEN : Q2 Earnings Snapshot
AQ
2021Repligen Reports Second Quarter 2021 Financial Results and Updates Full Year 2021 Finan..
GL
2021Repligen to Report Second Quarter 2021 Financial Results
GL
2021Repligen Corporation Announces Agreement to Acquire Polymem S.A.
GL
2021Repligen Corporation to Present at Upcoming Investor Conferences
GL
2021REPLIGEN CORP : Submission of Matters to a Vote of Security Holders (form 8-K)
AQ
2021REPLIGEN : 2020 Annual Report (PDF)
PU
2021REPLIGEN : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPER..
AQ
2021REPLIGEN : Reported revenue was $142.8 million for the quarter, representing year-over-yea..
PU
2021REPLIGEN : Q1 Earnings Snapshot
AQ
2021Repligen Reports First Quarter 2021 Financial Resultsáand Updates Full Year 2021 Financ..
GL
2021Repligen to Report First Quarter 2021 Financial Results
GL
2021Repligen Corporation to Present at KeyBanc Life Science and MedTech Investor Forum
GL
2021Repligen Corporation to Present at Barclays Global Healthcare Conference
GL
2021REPLIGEN : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPER..
AQ
2021REPLIGEN : 4Q Earnings Snapshot
AQ
2021Repligen Reports Fourth Quarter and Full Year 2020 Financial Results
GL
2021Repligen Corporation to Present at 10th Annual SVB Leerink Healthcare Conference
GL
2021Repligen to Report Fourth Quarter and Full Year 2020 Financial Results
GL
2021Repligen and Navigo Proteins Announce the Launch of an Affinity Resin for the Purificat..
GL
2021REPLIGEN CORP : Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial..
AQ
2021Repligen Corporation to Present at 39th Annual J.P. Morgan Healthcare Conference
GL
2020Repligen Corporation Announces Closing of Public Offering of $312.2 Million, Including ..
GL
2020REPLIGEN CORP : Entry into a Material Definitive Agreement, Other Events, Financial Statem..
AQ
2020REPLIGEN : EC Mergers & Acquisitions advised ARTeSYN on its Sale to Repligen
PR
2020Repligen Corporation Prices Public Offering of Shares of Common Stock
GL
2020Repligen Corporation Announces Proposed Public Offering of Shares of Common Stock
GL
2020REPLIGEN : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPER..
AQ
2020REPLIGEN : 3Q Earnings Snapshot
AQ
2020REPLIGEN : Reports Third Quarter 2020 Financial Results and Updates Full Year 2020 Financi..
AQ
2020Repligen Reports Third Quarter 2020 Financial Results and Updates Full Year 2020 Financ..
GL
2020REPLIGEN CORP : Regulation FD Disclosure, Other Events, Financial Statements and Exhibits ..
AQ
2020REPLIGEN CORPORATION : Announces Agreement to Acquire Bioprocess Systems Innovator ARTeSYN..
AQ
2020Repligen Corporation Announces Agreement to Acquire Bioprocess Systems Innovator ARTeSY..
GL
2020REPLIGEN : to Report Third Quarter 2020 Financial Results
AQ
2020Repligen to Report Third Quarter 2020 Financial Results
GL
2020REPLIGEN : and Navigo Proteins Announce Achievement of Key Milestone in Developing an Affi..
AQ
2020REPLIGEN : and Navigo Proteins Announce Achievement of Key Milestone in Developing an Affi..
AQ
2020Repligen and Navigo Proteins Announce Achievement of Key Milestone in Developing an Aff..
GL
2020REPLIGEN : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPER..
AQ
2020REPLIGEN : 2Q Earnings Snapshot
AQ
2020Repligen Reports Second Quarter 2020 Financial Results and Updates Full Year 2020 Finan..
GL
2020Repligen to Report Second Quarter 2020 Financial Results
GL
2020REPLIGEN CORP : Entry into a Material Definitive Agreement, Financial Statements and Exhib..
AQ
2020REPLIGEN : Current report filing
PU
2020REPLIGEN CORP : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
2020Repligen Announces Agreement to Acquire Engineered Molding Technology
GL
2020REPLIGEN CORP : Change in Directors or Principal Officers, Financial Statements and Exhibi..
AQ
2020Repligen Appoints Carrie Eglinton Manner to Board of Directors
GL
2020REPLIGEN CORP : Submission of Matters to a Vote of Security Holders (form 8-K)
AQ
2020REPLIGEN : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPER..
AQ
2020REPLIGEN : 1Q Earnings Snapshot
AQ
2020Repligen Reports First Quarter 2020 Financial Resultsáand Updates Full Year 2020 Financ..
GL
2020Repligen to Report First Quarter 2020 Financial Results
GL
2020REPLIGEN CORP : Change in Directors or Principal Officers, Financial Statements and Exhibi..
AQ
1  2  3  4  5Next
Upcoming event on REPLIGEN CORPORATION
02/24/22